Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer

被引:11
|
作者
Lee, Joo Yun [1 ]
Min, Yul Ha [1 ]
机构
[1] Gachon Univ, Coll Nursing, 191 Hambakmeo Ro, Incheon 21936, South Korea
来源
BMC WOMENS HEALTH | 2018年 / 18卷
基金
新加坡国家研究基金会;
关键词
Medication adherence; Breast cancer; Hormone therapy; Predisposing factor; MEDICATION ADHERENCE; SELF-EFFICACY; DEPRESSIVE SYMPTOMS; PATIENT-ADHERENCE; CLINICAL-PRACTICE; HORMONAL-THERAPY; WOMEN; NONADHERENCE; QUESTIONNAIRE; PERCEPTIONS;
D O I
10.1186/s12905-018-0522-3
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Interventions that promote adjuvant endocrine therapy (AET) adherence are critical to improve breast cancer survival. The development of interventions would benefit from a better understanding of the reasons for adherence and the causal relationships of determinants using theoretical or model approaches. The aim of the present study was to identify reasons for AET adherence in breast cancer patients with sequential relationships and inter-relationships. Methods: A total of 210 participants with estrogen receptor positive breast cancer who received AET completed a questionnaire assessing demographic/medical, psychological, and endocrine therapy (ET)-specific factors. A descriptive analysis was performed to identify meaningful variables. Selected variables were subjected to hierarchical regression and path analyses. The path model was tested and modified based on the research framework and the results of regression weights and model fit. Results: Analysis of sequential effects showed that ET-specific factors contributed the largest proportion of variance (13.4%) to predict AET adherence, followed by psychological factors (4.6%) and demographic/medical factors (3.1%). Analysis of inter-relationships showed that demographic/medical factors such as AET regimen type and cancer stage have direct effects on AET adherence, whereas psychological factors contribute indirectly through the mediating effects of ET-specific factors. Conclusion: Assessments and interventions that encompass the patient's medication beliefs, self-efficacy, and depression are needed to promote AET adherence.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Relationships between determinants of adjuvant endocrine therapy adherence in breast cancer
    Joo Yun Lee
    Yul Ha Min
    [J]. BMC Women's Health, 18
  • [2] Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
    Rosso, Roberta
    D'Alonzo, Marta
    Bounous, Valentina Elisabetta
    Actis, Silvia
    Cipullo, Isabella
    Salerno, Elena
    Biglia, Nicoletta
    [J]. CURRENT ONCOLOGY, 2023, 30 (02) : 1461 - 1472
  • [3] Male Breast Cancer and Adherence to Adjuvant Endocrine Therapy
    Lee, Inyoung
    Lee, Wan-Ju
    Calip, Gregory S.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 189 - 190
  • [4] Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer
    Calip, Gregory S.
    Xing, Shan
    Jun, Da-Hae
    Lee, Wan-Ju
    Hoskins, Kent F.
    Ko, Naomi Y.
    [J]. JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : E451 - E462
  • [5] Identifying determinants of adherence to adjuvant endocrine therapy following breast cancer: A systematic review of reviews
    Todd, Adam
    Waldron, Catherine
    Mcgeagh, Lucy
    Norris, Ruth
    Bolnykh, Iakov
    Stewart, Sarah Jane
    Slodkowska-Barabasz, Joanna
    Moon, Zoe
    Cahir, Caitriona
    Thompson, Sue
    Harmer, Victoria
    Wells, Mary
    Watson, Eila
    Sharp, Linda
    [J]. CANCER MEDICINE, 2024, 13 (03):
  • [6] Adherence to Endocrine Therapy in Breast Cancer Adjuvant and Prevention Settings
    Chlebowski, Rowan T.
    Kim, Jisang
    Haque, Reina
    [J]. CANCER PREVENTION RESEARCH, 2014, 7 (04) : 378 - 387
  • [7] Treatment Decisions and Adherence to Adjuvant Endocrine Therapy in Breast Cancer
    Wassermann J.
    Rosenberg S.M.
    [J]. Current Breast Cancer Reports, 2017, 9 (2) : 100 - 110
  • [8] Adherence to adjuvant endocrine therapy in postmenopausal women with breast cancer
    Ziller, V.
    Kalder, M.
    Albert, U. -S.
    Holzhauer, W.
    Ziller, M.
    Wagner, U.
    Hadji, P.
    [J]. ANNALS OF ONCOLOGY, 2009, 20 (03) : 431 - 436
  • [9] Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer
    Neuner, Joan M.
    Fergestrom, Nicole
    Pezzin, Liliana E.
    Laud, Purushottam W.
    Ruddy, Kathryn J.
    Winn, Aaron N.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (01) : 223 - 233
  • [10] Adherence to Adjuvant Endocrine Therapy in Christchurch Women with Early Breast Cancer
    Robinson, B.
    Dijkstra, B.
    Davey, V.
    Tomlinson, S.
    Frampton, C.
    [J]. CLINICAL ONCOLOGY, 2018, 30 (01) : E9 - E15